Gain Therapeutics to Present Positive Preclinical Data on it

Study results support the disease-modifying potential of structurally targeted allosteric regulators of GCase for the treatment of Alzheimer’s diseaseBETHESDA, Md., March 29, 2023 -- Gain... | March 29, 2023

Related Keywords

Sweden , Gothenburg , Vastra Gotalands Lan , Joanne Taylor , Matthias Alder , Exchange Commission , Nasdaq , Company Annual Report On Form , Gain Therapeutics Inc , Michaelj Fox Foundation For Parkinson Research , Exchange Commission On , Silverstein Foundation For Parkinson , Head Of Research , International Conference On Alzheimer , Science Technology , European Union Horizon , Chief Executive , Amyloid Beta , Cell Based Models , Gain Therapeutics , Silverstein Foundation , Private Securities Litigation Reform Act , Annual Report , Media Contact , Nc Stock Exchange , News , Information , Press Release , Study , Results , Support , The , Potential , F , Structurally , Argeted , Llosteric , Regulators , Case , Or , Treatment , Arch , 023 Ganx Us36269b1052 ,